Berry Genomics Co

Berry Genomics Co Tax Rate

The Effective Tax Rate of Berry Genomics Co (000710.SZ) as of Oct 29, 2026 is -3.55 %. In the previous year, Effective Tax Rate was -10.20 % — a change of -65.15% (higher).

Tax Rate

-3.55 %

YoY

-65.15%

Last updated:

Effective Tax Rate of Berry Genomics Co is 2025 -3.55 % . Effective Tax Rate of Berry Genomics Co was 2024 -10.20 % . It decreases by -65.15% higher compared to the previous year.

The Berry Genomics Co Tax Rate history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Rate
Date
Tax Rate
Jan 1, 2018
16.46 CNY
Jan 1, 2019
13.13 CNY
Jan 1, 2020
16.16 CNY
Jan 1, 2021
8.74 CNY
Jan 1, 2022
10.85 CNY
Jan 1, 2023
6.21 CNY
Jan 1, 2024
-10.20 CNY
Jan 1, 2025
-3.55 CNY
The Berry Genomics Co Tax Rate history
YEARTax RateYoY
-3.55 %-65.15%
-10.20 %-264.25%
6.21 %-42.74%
10.85 %+24.13%
8.74 %-45.94%
16.16 %+23.05%
13.13 %-20.19%
16.46 %+17.58%
14.00 %+2.19%
13.70 %-13.22%
15.78 %-11.94%
17.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Berry Genomics Co Stock analysis

What does Berry Genomics Co do? Berry Genomics Co., Ltd. generates revenue through basic scientific research services, medical testing services, and the sale of reagents and equipment. The company provides transcriptome sequencing, human whole exome sequencing, and whole genome sequencing for scientific research clients. Medical testing services include tumor genetic testing, genetic disease testing, and reproductive health testing for healthcare providers. Reagent and equipment sales feature the NextSeq CN500 gene sequencer and general reagents for sequencing reactions, targeting research institutions and medical facilities. The primary buyers of basic scientific research services are research institutions requiring advanced sequencing platforms. Medical testing services are purchased by healthcare providers offering diagnostic solutions. Reagent and equipment sales target both research and medical sectors, with the NextSeq CN500 gene sequencer being a key product for high-throughput sequencing needs. The company's revenue streams are segmented by service type, with research services and medical testing forming the core business segments. Berry Genomics' product portfolio includes sequencing platforms, testing reagents, and equipment like the NextSeq CN500 gene sequencer. These products serve research institutions and medical facilities, with medical testing services focusing on tumor, genetic disease, and reproductive health applications. The company's sales strategy emphasizes high-throughput sequencing technology solutions for both scientific and medical markets. Berry Genomics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Berry Genomics Co stock

Effective Tax Rate of Berry Genomics Co is -3.55 % in 2025.

Effective Tax Rate of Berry Genomics Co changed from -10.20 % to -3.55 %, representing a -65.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Effective Tax Rate Berry Genomics Co since 2006 – with annual values, charts, and detailed analysis.

The effective tax rate measures the actual percentage of pretax income paid in taxes. It reflects the company's tax efficiency and planning.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Effective Tax Rate's Berry Genomics Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Effective Tax Rate's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Effective Tax Rate.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Berry Genomics Co

All Key Metrics — Berry Genomics Co